The Relationship Between Dietary Intake of ω-3 and ω-6 Fatty Acids and Frailty Risk in Middle-aged and Elderly Individuals: a Cross-sectional Study from NHANES

Overview

Journal Front Nutr

Specialty Nutritional Sciences

Date 2024 May 24

PMID 38784137

Authors

Zhaoqi Yan

Yifeng Xu

Keke Li

Wenqiang Zhang

Liangji Liu

Affiliations

Soon will be listed here.

Abstract

Background: Frailty is a complex clinical syndrome characterized by a decline in the functioning of multiple body systems and reduced adaptability to external stressors. Dietary ω-3 fatty acids are considered beneficial dietary nutrients for preventing frailty due to their anti-inflammatory and immune-regulating properties. However, previous research has yielded conflicting results, and the association between ω-6 fatty acids, the ω-6: ω-3 ratio, and frailty remains unclear. This study aims to explore the relationship between these factors using the National Health and Nutrition Examination Survey (NHANES) database.

Materials And Methods: Specialized weighted complex survey design analysis software was employed to analyze data from the 2005-2014 NHANES, which included 12,315 participants. Multivariate logistic regression models and restricted cubic splines (RCS) were utilized to assess the relationship between omega intake and frailty risk in all participants. Additionally, a nomogram model for predicting frailty risk was developed based on risk factors. The reliability of the clinical model was determined by the area under the receiver operating characteristic (ROC) curve, calibration curves, and decision curve analysis (DCA).

Results: In dietary ω-3 intake, compared to the T1 group (≤1.175 g/d), the T3 group's intake level (>2.050 g/d) was associated with approximately 17% reduction in frailty risk in model 3, after rigorous covariate adjustments (odds ratio (OR) = 0.83, 95% confidence interval (CI): (0.70, 0.99)). In dietary ω-6 intake, the T2 group's intake level (>11.423, ≤19.160 g/d) was associated with a 14% reduction in frailty risk compared to the T1 group (≤11.423 g/d) (OR: 0.86, 95% CI: 0.75, 1.00, = 0.044). RCS results indicated a non-linear association between ω-3 and ω-6 intake and frailty risk. Both ROC and DCA curves demonstrated the stability of the constructed model and the effectiveness of an omega-rich diet in reducing frailty risk. However, we did not find a significant association between the ω-6: ω-3 ratio and frailty.

Conclusion: This study provides support for the notion that a high intake of ω-3 and a moderate intake of ω-6 may contribute to reducing frailty risk in middle-aged and elderly individuals.

Citing Articles

Comparing Nutritional Values and Bioactivity of Kefir from Different Types of Animal Milk.

La Torre C, Caputo P, Cione E, Fazio A Molecules. 2024; 29(11).

PMID: 38893583 PMC: 11173642. DOI: 10.3390/molecules29112710.

References

Hernandez Morante J, Martinez C, Morillas-Ruiz J . Dietary Factors Associated with Frailty in Old Adults: A Review of Nutritional Interventions to Prevent Frailty Development. Nutrients. 2019; 11(1). PMC: 6356476. DOI: 10.3390/nu11010102. View

Krzyminska-Siemaszko R, Czepulis N, Lewandowicz M, Zasadzka E, Suwalska A, Witowski J . The Effect of a 12-Week Omega-3 Supplementation on Body Composition, Muscle Strength and Physical Performance in Elderly Individuals with Decreased Muscle Mass. Int J Environ Res Public Health. 2015; 12(9):10558-74. PMC: 4586628. DOI: 10.3390/ijerph120910558. View

Patel H, Syddall H, Jameson K, Robinson S, Denison H, Roberts H . Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS). Age Ageing. 2013; 42(3):378-84. PMC: 3633365. DOI: 10.1093/ageing/afs197. View

Tortosa-Caparros E, Navas-Carrillo D, Marin F, Orenes-Pinero E . Anti-inflammatory effects of omega 3 and omega 6 polyunsaturated fatty acids in cardiovascular disease and metabolic syndrome. Crit Rev Food Sci Nutr. 2016; 57(16):3421-3429. DOI: 10.1080/10408398.2015.1126549. View

Stratos I, Behrendt A, Anselm C, Gonzalez A, Mittlmeier T, Vollmar B . Inhibition of TNF-α Restores Muscle Force, Inhibits Inflammation, and Reduces Apoptosis of Traumatized Skeletal Muscles. Cells. 2022; 11(15). PMC: 9367740. DOI: 10.3390/cells11152397. View

Roberts M, Iosia M, Kerksick C, Taylor L, Campbell B, Wilborn C . Effects of arachidonic acid supplementation on training adaptations in resistance-trained males. J Int Soc Sports Nutr. 2007; 4:21. PMC: 2217562. DOI: 10.1186/1550-2783-4-21. View

ODonovan M, Sezgin D, Liew A, OCaoimh R . Burden of disease, disability-adjusted life years and frailty prevalence. QJM. 2018; 112(4):261-267. DOI: 10.1093/qjmed/hcy291. View

Sandoval-Insausti H, Perez-Tasigchana R, Lopez-Garcia E, Garcia-Esquinas E, Rodriguez-Artalejo F, Guallar-Castillon P . Macronutrients Intake and Incident Frailty in Older Adults: A Prospective Cohort Study. J Gerontol A Biol Sci Med Sci. 2016; 71(10):1329-34. DOI: 10.1093/gerona/glw033. View

Hutchins-Wiese H, Kleppinger A, Annis K, Liva E, Lammi-Keefe C, Durham H . The impact of supplemental n-3 long chain polyunsaturated fatty acids and dietary antioxidants on physical performance in postmenopausal women. J Nutr Health Aging. 2013; 17(1):76-80. DOI: 10.1007/s12603-012-0415-3. View

10.

Jeromson S, Gallagher I, Galloway S, Hamilton D . Omega-3 Fatty Acids and Skeletal Muscle Health. Mar Drugs. 2015; 13(11):6977-7004. PMC: 4663562. DOI: 10.3390/md13116977. View

11.

Orkaby A, Dushkes R, Ward R, Djousse L, Buring J, Lee I . Effect of Vitamin D3 and Omega-3 Fatty Acid Supplementation on Risk of Frailty: An Ancillary Study of a Randomized Clinical Trial. JAMA Netw Open. 2022; 5(9):e2231206. PMC: 9471979. DOI: 10.1001/jamanetworkopen.2022.31206. View

12.

Custodero C, Mankowski R, Lee S, Chen Z, Wu S, Manini T . Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis. Ageing Res Rev. 2018; 46:42-59. PMC: 6235673. DOI: 10.1016/j.arr.2018.05.004. View

13.

Leon-Munoz L, Garcia-Esquinas E, Lopez-Garcia E, Banegas J, Rodriguez-Artalejo F . Major dietary patterns and risk of frailty in older adults: a prospective cohort study. BMC Med. 2015; 13:11. PMC: 4298966. DOI: 10.1186/s12916-014-0255-6. View

14.

Innes J, Calder P . Omega-6 fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids. 2018; 132:41-48. DOI: 10.1016/j.plefa.2018.03.004. View

15.

Singh J . Dietary Sources of Omega-3 Fatty Acids Versus Omega-3 Fatty Acid Supplementation Effects on Cognition and Inflammation. Curr Nutr Rep. 2020; 9(3):264-277. DOI: 10.1007/s13668-020-00329-x. View

16.

Feingold K . The outer frontier: the importance of lipid metabolism in the skin. J Lipid Res. 2008; 50 Suppl:S417-22. PMC: 2674689. DOI: 10.1194/jlr.R800039-JLR200. View

17.

Troesch B, Eggersdorfer M, Laviano A, Rolland Y, Smith A, Warnke I . Expert Opinion on Benefits of Long-Chain Omega-3 Fatty Acids (DHA and EPA) in Aging and Clinical Nutrition. Nutrients. 2020; 12(9). PMC: 7551800. DOI: 10.3390/nu12092555. View

18.

. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25):3143-421. View

19.

Angulo J, El Assar M, Alvarez-Bustos A, Rodriguez-Manas L . Physical activity and exercise: Strategies to manage frailty. Redox Biol. 2020; 35:101513. PMC: 7284931. DOI: 10.1016/j.redox.2020.101513. View

20.

Pereira M, Liang J, Edwards-Hicks J, Meadows A, Hinz C, Liggi S . Arachidonic acid inhibition of the NLRP3 inflammasome is a mechanism to explain the anti-inflammatory effects of fasting. Cell Rep. 2024; 43(2):113700. PMC: 10940735. DOI: 10.1016/j.celrep.2024.113700. View